PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity

Patricio Oyarzún, Jonathan J. Ellis, Mikael Bodén, Bostjan Kobe. PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity. BMC Bioinformatics, 14:52, 2013. [doi]

@article{OyarzunEBK13,
  title = {PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity},
  author = {Patricio Oyarzún and Jonathan J. Ellis and Mikael Bodén and Bostjan Kobe},
  year = {2013},
  doi = {10.1186/1471-2105-14-52},
  url = {http://dx.doi.org/10.1186/1471-2105-14-52},
  researchr = {https://researchr.org/publication/OyarzunEBK13},
  cites = {0},
  citedby = {0},
  journal = {BMC Bioinformatics},
  volume = {14},
  pages = {52},
}